Home » All » Stock Forecast » BioXcel Therapeutics Inc. Common Stock Forecast

BioXcel Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -4.17%Market Cap $31.14M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$1.17 ▲ +1.41%	Yesterday	$1.14 ▼ -0.59%	Tomorrow's BioXcel Therapeutics Inc. Common Stock (BTAI) setup is anchored to $1.15 and targets $1.17 (+1.41%). The near-term read is upside; watch $1.18 / $1.12 because daily realized volatility is about 7.29%.
Tomorrow's BioXcel Therapeutics Inc. Common Stock (BTAI) setup is anchored to $1.15 and targets $1.17 (+1.41%). The near-term read is upside; watch $1.18 / $1.12 because daily realized volatility is about 7.29%.
Week	$1.20 ▲ +4.40%	Last Week	$1.13 ▼ -1.85%	The 7-day BioXcel Therapeutics Inc. Common Stock model moves from $1.13 to $1.20 (+4.40%). It gives upside momentum context for this stock, so breaks around $1.18 / $1.12 matter more than a single tick.
The 7-day BioXcel Therapeutics Inc. Common Stock model moves from $1.13 to $1.20 (+4.40%). It gives upside momentum context for this stock, so breaks around $1.18 / $1.12 matter more than a single tick.
Month	$1.26 ▲ +9.37%	Last Month	$1.10 ▼ -3.94%	The 1-month BioXcel Therapeutics Inc. Common Stock target is $1.26 (+9.37%), compared with the live reference near $1.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month BioXcel Therapeutics Inc. Common Stock target is $1.26 (+9.37%), compared with the live reference near $1.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$1.34 ▲ +16.82%	Last Year	$1.07 ▼ -7.07%	The 1-year BioXcel Therapeutics Inc. Common Stock scenario points to $1.34 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year BioXcel Therapeutics Inc. Common Stock scenario points to $1.34 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$1.54 ▲ +34.29%	5 Years Ago	$0.9844 ▼ -14.40%	The 5-year BioXcel Therapeutics Inc. Common Stock view is $1.54 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year BioXcel Therapeutics Inc. Common Stock view is $1.54 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$1.17▲ +1.41%

Yesterday$1.14▼ -0.59%

Tomorrow's BioXcel Therapeutics Inc. Common Stock (BTAI) setup is anchored to $1.15 and targets $1.17 (+1.41%). The near-term read is upside; watch $1.18 / $1.12 because daily realized volatility is about 7.29%.

Week$1.20▲ +4.40%

Last Week$1.13▼ -1.85%

The 7-day BioXcel Therapeutics Inc. Common Stock model moves from $1.13 to $1.20 (+4.40%). It gives upside momentum context for this stock, so breaks around $1.18 / $1.12 matter more than a single tick.

Month$1.26▲ +9.37%

Last Month$1.10▼ -3.94%

The 1-month BioXcel Therapeutics Inc. Common Stock target is $1.26 (+9.37%), compared with the live reference near $1.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$1.34▲ +16.82%

Last Year$1.07▼ -7.07%

The 1-year BioXcel Therapeutics Inc. Common Stock scenario points to $1.34 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$1.54▲ +34.29%

5 Years Ago$0.9844▼ -14.40%

The 5-year BioXcel Therapeutics Inc. Common Stock view is $1.54 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$1.15	Mid
Daily Change	-4.17%	Below
Volatility Cap	20.0%	Mid
Confidence	66%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$1.15

Daily Change-4.17%

Market Cap$31.14M

Sourcenasdaq-screener

Current	$1.15	Daily Change	-4.17%
Market Cap	$31.14M	Source	nasdaq-screener

Support & Resistance Levels

$1.12Support 1

$1.15Current

$1.18Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$1.15Live reference price

Used as the anchor for generated forecast calculations.

Next Month$1.26Model projection+9.37%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

66%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

66%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in BTAI today

Bullish Scenario

$1.21

+5.00% from current

Target Price$1.21

ScenarioUpside momentum

Probability58%

Base Scenario

$1.26

+9.37%

Target Price$1.26

ScenarioCapped drift

Probability66%

Bearish Scenario

$1.09

-5.00% from current

Target Price$1.09

ScenarioVolatility drawdown

Probability34%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 70/100

24H drift+1.41%

7D drift+4.40%

30D drift+9.37%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 67/100

1M outlook+9.37%

1Y outlook+16.82%

5Y outlook+34.29%

Frequently Asked Questions

Q What is the BioXcel Therapeutics Inc. Common Stock (BTAI) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), BioXcel Therapeutics Inc. Common Stock is projected near $1.17 versus the current reference around $1.15. That implies a modeled move of +1.41% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for BTAI?

The weekly BioXcel Therapeutics Inc. Common Stock model points to $1.20, which maps to an expected drift of +4.40% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the BioXcel Therapeutics Inc. Common Stock 1-month and 1-year targets?

The BioXcel Therapeutics Inc. Common Stock 1-month target is $1.26 (+9.37%), while the 1-year target is $1.34 (+16.82%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the BioXcel Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The BioXcel Therapeutics Inc. Common Stock long-horizon scenario sits near $1.54 with a modeled change of +34.29%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are BTAI support and resistance zones right now?

For BioXcel Therapeutics Inc. Common Stock, nearest resistance is around $1.12, while nearest support is around $1.18. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the BioXcel Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.